It remains to be determined whether MAPK signaling-mediated upregulation of MDM4 expression has a prognostic impact on HCC patients after liver resection (Figure 1D), as we were not able to independently validate this finding using the TGCA data set (Figure S2E,F), suggesting the possibility of a cohort-related bias. This evidence concerns the gene MDM4 and hepatocellular carcinoma.